1-7 of 7
Chunmei Zhou, MS
Close
Sort by
Journal Articles

Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study

Baba Inusa, Raffaella Colombatti, MD PhD, David C Rees, MA, FRCP, Matthew M Heeney, MD, Carolyn C Hoppe, MD, Bernhards Ogutu, MD PhD, Hoda M Hassab, MD, Chunmei Zhou, MS, Suqin Yao, PhD, Patricia B Brown, BSN, RN, Lori E Heath, MS, Joseph A. Jakubowski, PhD, Miguel R Abboud, MD
Journal: Blood
Blood (2016) 128 (22): 3653.
https://doi.org/10.1182/blood.V128.22.3653.3653
Published: 2016
Journal Articles

Regional- and Age-Related Differences in Pain in Children with Sickle Cell Anemia: Results from the Multinational DOVE Study

Julie Kanter, MD, Lori E Heath, MS, Chunmei Zhou, MS, Tsiri Agbenyega, MBChB, PhD, Raffaella Colombatti, MD PhD, Carlton Dampier, MD CPI, Hoda M Hassab, MD, Deepa Manwani, MD, Nancy Robitaille, MD, Patricia B Brown, BSN, RN, Joseph A. Jakubowski, PhD, Suqin Yao, PhD, Jack Knorr, PhD, Carolyn C Hoppe, MD
Journal: Blood
Blood (2016) 128 (22): 3654.
https://doi.org/10.1182/blood.V128.22.3654.3654
Published: 2016
Journal Articles

Prasugrel in Children with Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Characteristics from an Open-Label, Adaptive-Design, Dose-Ranging Study

Lori Styles, MD, Joseph A. Jakubowski, PhD, Darell E. Heiselman, MD, Lori E. Heath, MS, Chunmei Zhou, MS, Charles T. Quinn, MD, MS, Matthew M. Heeney, MD, Rupa Redding-Lallinger, MD, David S. Small, PhD, Brian A. Moser, MS, Kenneth J. Winters, MD
Journal: Blood
Blood (2012) 120 (21): 3213.
https://doi.org/10.1182/blood.V120.21.3213.3213
Published: 2012
Journal Articles

Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease

Ted Wun, Charles L. Knupp, MD, Lillian E. McMahon, MD, John J. Strouse, MD, PhD, Chunmei Zhou, MS, Lori E. Heath, MS, Chuke E. Nwachuku, MA, MPH, DrPH, Joseph A. Jakubowski, PhD, Kenneth J. Winters, MD, Jeffrey S. Riesmeyer, MD
Journal: Blood
Blood (2011) 118 (21): 2127.
https://doi.org/10.1182/blood.V118.21.2127.2127
Published: 2011
Journal Articles

A Randomized, Double-Blind, Adaptive Phase 2 Multi-Center Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease

Ted Wun, Denis Soulieres, MD, FRCPC, MSc, Lakshmanan Krishnamurti, MD, Abdullah Kutlar, MD, Kenneth Ataga, MD, Chunmei Zhou, MS, Lori E. Heath, MS, Chuke E. Nwachuku, MA, MPH, DrPH, Joseph A. Jakubowski, PhD, Kenneth J. Winters, MD, Jeffrey S. Riesmeyer, MD
Journal: Blood
Blood (2011) 118 (21): 847.
https://doi.org/10.1182/blood.V118.21.847.847
Published: 2011
Journal Articles

A Phase 1 Study of Prasugrel in Subjects with Sickle Cell Disease: Impact on Ex Vivo Platelet Reactivity

Joseph A. Jakubowski, PhD, Chunmei Zhou, MS, David S. Small, PhD, Kenneth J. Winters, MD, D. Richard Lachno, DPhil, Andrew L. Frelinger, III, PhD, Jo Howard, MB, BChir, MRCP, FRCPath, Stipo Jurcevic, MD, Christopher D. Payne, MSc
Journal: Blood
Blood (2011) 118 (21): 1053.
https://doi.org/10.1182/blood.V118.21.1053.1053
Published: 2011
Journal Articles

A Phase 1 Study of Prasugrel in Subjects with Sickle Cell Disease: Effects on In Vivo Markers of Platelet Activation and of Coagulation

Joseph A. Jakubowski, PhD, Chunmei Zhou, MS, David S. Small, PhD, Kenneth J. Winters, MD, D. Richard Lachno, DPhil, Andrew L. Frelinger, III, PhD, Jo Howard, MB, BChir, MRCP, FRCPath, Stipo Jurcevic, MD, Christopher D. Payne, MSc
Journal: Blood
Blood (2011) 118 (21): 1049.
https://doi.org/10.1182/blood.V118.21.1049.1049
Published: 2011